Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2014 (2014), Article ID 472949, 8 pages
http://dx.doi.org/10.1155/2014/472949
Research Article

Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study

1Department of Urology, University of Pisa, 56126 Pisa, Italy
2Skåne University Hospital, SE 205 02 Malmö, Sweden
3Hospital Ramon y Cajal, 28034 Madrid, Spain
4GlaxoSmithKline, Research Triangle Park, NC 27709, USA
5GlaxoSmithKline, Urology Centre of Excellence, C/Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain
6GlaxoSmithKline, Health Outcomes Studies, 78160 Marly-Le-Roi, France
7GlaxoSmithKline, King of Prussia, PA 19406, USA

Received 21 October 2013; Revised 29 January 2014; Accepted 29 January 2014; Published 13 March 2014

Academic Editor: Michael Zelefsky

Copyright © 2014 Cesare Selli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray et al., GLOBOCAN, 2008, Cancer Incidence and Mortality Worldwide, IARC CancerBase No. 10, International Agency for Research on Cancer, Lyon, France, 2010.
  2. J. Ferlay, D. M. Parkin, and E. Steliarova-Foucher, “Estimates of cancer incidence and mortality in Europe in 2008,” European Journal of Cancer, vol. 46, no. 4, pp. 765–781, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. R. Cooperberg, J. M. Broering, P. W. Kantoff, and P. R. Carroll, “Contemporary trends in low risk prostate cancer: risk assessment and treatment,” Journal of Urology, vol. 178, no. 3, pp. S14–S19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Cooperberg, J. M. Broering, and P. R. Carroll, “Time trends and local variation in primary treatment of localized prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 7, pp. 1117–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Á. R. Helgason, J. Adolfsson, P. Dickman, S. Arver, M. Fredrikson, and G. Steineck, “Factors associated with waning sexual function among elderly men and prostate cancer patients,” Journal of Urology, vol. 158, no. 1, pp. 155–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Sanda, R. L. Dunn, J. Michalski et al., “Quality of life and satisfaction with outcome among prostate-cancer survivors,” The New England Journal of Medicine, vol. 358, no. 12, pp. 1250–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mehnert, C. Lehmann, T. Schulte, and U. Koch, “Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation,” Onkologie, vol. 30, no. 11, pp. 551–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Mols, I. J. Korfage, A. J. J. M. Vingerhoets et al., “Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 1, pp. 30–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. Penson, D. McLerran, Z. Feng et al., “5-Year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study,” Journal of Urology, vol. 173, no. 5, pp. 1701–1705, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ferrer, F. Guedea, J. F. Suarez et al., “Quality of life impact of treatments for localized prostate cancer: cohort study with a 5-year follow-up,” Radiotherapy and Oncology, vol. 108, pp. 306–313, 2013. View at Google Scholar
  11. A. V. D'Amico, R. Whittington, S. Bruce Malkowicz et al., “Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer,” Journal of the American Medical Association, vol. 280, no. 11, pp. 969–974, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. G. van Andel, A. Bottomley, S. D. Fosså et al., “An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer,” European Journal of Cancer, vol. 44, no. 16, pp. 2418–2424, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. K. Aaronson, S. Ahmedzai, B. Bergman et al., “The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology,” Journal of the National Cancer Institute, vol. 85, no. 5, pp. 365–376, 1993. View at Google Scholar · View at Scopus
  14. R. P. Snaith, “The hospital anxiety and depression scale,” Health and Quality of Life Outcomes, vol. 1, article 29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Johansson, A. Bill-Axelson, L. Holmberg, E. Onelöv, J.-E. Johansson, and G. Steineck, “Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the randomized scandinavian prostate cancer group study number 4 (SPCG-4) clinical trial,” European Urology, vol. 55, no. 2, pp. 422–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Ferrer, J. F. Suárez, F. Guedea et al., “Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 2, pp. 421–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Johansson, G. Steineck, L. Holmberg et al., “Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial,” The Lancet Oncology, vol. 12, no. 9, pp. 891–899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Namiki, S. Ishidoya, S. Kawamura, T. Tochigi, and Y. Arai, “Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 3, pp. 379–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Resnick, T. Koyama, K. H. Fan et al., “Long-term functional outcomes after treatment for localized prostate cancer,” The New England Journal of Medicine, vol. 368, pp. 436–445, 2013. View at Google Scholar
  20. W. R. Parker, J. S. Montgomery, and D. P. Wood Jr., “Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?” Current Opinion in Urology, vol. 19, no. 3, pp. 303–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Etzioni, L. Mucci, S. Chen et al., “Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden,” Clinical Cancer Research, vol. 18, pp. 6742–6747, 2012. View at Google Scholar
  22. J. Maringwa, C. Quinten, M. King et al., “Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients,” Annals of Oncology, vol. 22, no. 9, pp. 2107–2112, 2011. View at Publisher · View at Google Scholar